Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Interest & Investment Income: 2010-2015

Historic Interest & Investment Income for EyePoint Pharmaceuticals (EYPT) over the last 4 years, with Jun 2015 value amounting to $7,000.

  • EyePoint Pharmaceuticals' Interest & Investment Income rose 133.33% to $7,000 in Q2 2015 from the same period last year, while for Jun 2015 it was $19,000, marking a year-over-year increase of 216.67%. This contributed to the annual value of $19,000 for FY2015, which is 216.67% up from last year.
  • EyePoint Pharmaceuticals' Interest & Investment Income amounted to $7,000 in Q2 2015, which was up 16.67% from $6,000 recorded in Q1 2015.
  • EyePoint Pharmaceuticals' 5-year Interest & Investment Income high stood at $11,000 for Q2 2011, and its period low was $1,000 during Q3 2013.
  • For the 3-year period, EyePoint Pharmaceuticals' Interest & Investment Income averaged around $3,000, with its median value being $3,000 (2014).
  • In the last 5 years, EyePoint Pharmaceuticals' Interest & Investment Income crashed by 85.71% in 2013 and then skyrocketed by 500.00% in 2015.
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' Interest & Investment Income stood at $11,000 in 2011, then tumbled by 63.64% to $4,000 in 2012, then crashed by 75.00% to $1,000 in 2013, then spiked by 200.00% to $3,000 in 2014, then surged by 133.33% to $7,000 in 2015.
  • Its last three reported values are $7,000 in Q2 2015, $6,000 for Q1 2015, and $3,000 during Q4 2014.